Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients

This study is designed to investigate whether the use of copanlisib is safe, feasible and beneficial to pediatric patients with solid solid tumors or lymphoma that are recurrent or refractory to standard therapy.

NCT: NCT03458728

Locations: University of Minnesota Medical Center, Ann & Robert H. Lurie Children’s Hospital of Chicago

Link: https://clinicaltrials.gov/ct2/show/NCT03458728?recrs=ad&cond=Neuroblastoma&locn=University+of+Minnesota&cntry=US&age=0&draw=4&rank=29